Aspire Biopharma, Stock Market Value
| ASBP Stock | 0.09 0 2.16% |
| Symbol | Aspire |
Aspire BioPharma, Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspire BioPharma,. If investors know Aspire will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspire BioPharma, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aspire BioPharma, is measured differently than its book value, which is the value of Aspire that is recorded on the company's balance sheet. Investors also form their own opinion of Aspire BioPharma,'s value that differs from its market value or its book value, called intrinsic value, which is Aspire BioPharma,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspire BioPharma,'s market value can be influenced by many factors that don't directly affect Aspire BioPharma,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspire BioPharma,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Aspire BioPharma, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspire BioPharma,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Aspire BioPharma, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aspire BioPharma,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aspire BioPharma,.
| 11/24/2025 |
| 12/24/2025 |
If you would invest 0.00 in Aspire BioPharma, on November 24, 2025 and sell it all today you would earn a total of 0.00 from holding Aspire BioPharma, or generate 0.0% return on investment in Aspire BioPharma, over 30 days. Aspire BioPharma, is related to or competes with Cencora, Regeneron Pharmaceuticals, IDEXX Laboratories, Haleon Plc, Cigna Corp, Elevance Health, and Becton Dickinson. Aspire BioPharma, is entity of United States More
Aspire BioPharma, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aspire BioPharma,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aspire BioPharma, upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 137.5 | |||
| Value At Risk | (20.00) | |||
| Potential Upside | 17.23 |
Aspire BioPharma, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aspire BioPharma,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aspire BioPharma,'s standard deviation. In reality, there are many statistical measures that can use Aspire BioPharma, historical prices to predict the future Aspire BioPharma,'s volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (1.17) | |||
| Total Risk Alpha | (2.47) | |||
| Treynor Ratio | (2.06) |
Aspire BioPharma, Backtested Returns
Aspire BioPharma, secures Sharpe Ratio (or Efficiency) of -0.0666, which signifies that the company had a -0.0666 % return per unit of risk over the last 3 months. Aspire BioPharma, exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aspire BioPharma,'s Risk Adjusted Performance of (0.04), mean deviation of 8.05, and Standard Deviation of 16.13 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.55, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Aspire BioPharma,'s returns are expected to increase less than the market. However, during the bear market, the loss of holding Aspire BioPharma, is expected to be smaller as well. At this point, Aspire BioPharma, has a negative expected return of -1.1%. Please make sure to confirm Aspire BioPharma,'s information ratio, potential upside, as well as the relationship between the Potential Upside and rate of daily change , to decide if Aspire BioPharma, performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.09 |
Very weak reverse predictability
Aspire BioPharma, has very weak reverse predictability. Overlapping area represents the amount of predictability between Aspire BioPharma, time series from 24th of November 2025 to 9th of December 2025 and 9th of December 2025 to 24th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aspire BioPharma, price movement. The serial correlation of -0.09 indicates that less than 9.0% of current Aspire BioPharma, price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.09 | |
| Spearman Rank Test | -0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Aspire BioPharma, lagged returns against current returns
Autocorrelation, which is Aspire BioPharma, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Aspire BioPharma,'s stock expected returns. We can calculate the autocorrelation of Aspire BioPharma, returns to help us make a trade decision. For example, suppose you find that Aspire BioPharma, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Aspire BioPharma, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Aspire BioPharma, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Aspire BioPharma, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Aspire BioPharma, stock over time.
Current vs Lagged Prices |
| Timeline |
Aspire BioPharma, Lagged Returns
When evaluating Aspire BioPharma,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Aspire BioPharma, stock have on its future price. Aspire BioPharma, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Aspire BioPharma, autocorrelation shows the relationship between Aspire BioPharma, stock current value and its past values and can show if there is a momentum factor associated with investing in Aspire BioPharma,.
Regressed Prices |
| Timeline |
Pair Trading with Aspire BioPharma,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aspire BioPharma, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aspire BioPharma, will appreciate offsetting losses from the drop in the long position's value.Moving together with Aspire Stock
| 0.74 | NVO | Novo Nordisk AS Buyout Trend | PairCorr |
Moving against Aspire Stock
| 0.89 | MTC | MMTEC Inc Tech Boost | PairCorr |
| 0.86 | MRK | Merck Company Aggressive Push | PairCorr |
| 0.85 | JNJ | Johnson Johnson | PairCorr |
| 0.83 | GSK | GlaxoSmithKline PLC ADR | PairCorr |
| 0.82 | AZN | AstraZeneca PLC ADR | PairCorr |
The ability to find closely correlated positions to Aspire BioPharma, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aspire BioPharma, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aspire BioPharma, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aspire BioPharma, to buy it.
The correlation of Aspire BioPharma, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aspire BioPharma, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aspire BioPharma, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aspire BioPharma, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Aspire Stock Analysis
When running Aspire BioPharma,'s price analysis, check to measure Aspire BioPharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspire BioPharma, is operating at the current time. Most of Aspire BioPharma,'s value examination focuses on studying past and present price action to predict the probability of Aspire BioPharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aspire BioPharma,'s price. Additionally, you may evaluate how the addition of Aspire BioPharma, to your portfolios can decrease your overall portfolio volatility.